Medicinal cannabis is any cannabis-based product prescribed to relieve the symptoms of a medical condition.
A tech partnership means that carers can now access a tool to help identify, monitor and reduce pain in dementia aged-care residents.
Molecules from the venom of one of the world's largest spiders could be used to develop pain blockers for people with irritable bowel syndrome.
Australians suffering with chronic pain have reported a worsening in their relationship with their GP and pharmacist over the past two years, according to the National Pain Survey 2020.
Injuries sustained in a car accident left Mary in intense pain — she was eventually diagnosed with complex regional pain syndrome.
This National Pain Week — running from 27 July to 2 August — aims to bust some of the myths and stigma surrounding chronic pain.
Research from the University of South Australia shows that fentanyl is a safe option for mothers and babies, providing women with more pain relief choices during labour.
Medical professionals can now access a TGA-approved device to treat patients with chronic back pain, which affects 3.24 million Australians.
National Drug Research Institute has released the first national update on the cost of opioids in 13 years — it's not a pretty picture.
The wafer has been designed to provide rapid and more predictable absorption of cannabis, improved bioavailability and the potential for faster therapeutic action.
An AIHW report explores the latest national data on the proportion of people with chronic pain, as well as its impact, treatment and management.
How do we best respond to the pain experienced by some of the most frail and vulnerable people in our communities?
The move to prescription-only codeine in Australia has seen a 50% reduction in the monthly rate of codeine-related poisoning calls and halved codeine sales.
A new Australian prevalence study of hidradenitis suppurativa finds a high number of Australians have the devastating skin condition.
Estrogen and other sex hormones may be responsible for the higher prevalence of migraine in women.